Boulder, CO, United States of America

Scott Schmidt

This inventor holds 1 USPTO granted patent. Top assignee: Precigen, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Schmidt - Innovator in Electroporation Technology

Introduction

Scott Schmidt is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on electroporation technology. His expertise and dedication have led to advancements that enhance the delivery of therapeutic agents into cells.

Latest Patents

Scott Schmidt holds a patent for an "Electroporation apparatus and method." Electroporation is a technique that applies an electrical field to cells, increasing the permeability of the cell membrane. This process allows for the introduction of chemicals, drugs, and macromolecules such as proteins and nucleic acids into the cells. His electroporation apparatus comprises a plurality of chambers designed to store cells during the electroporation process, electrodes to generate electric fields, a flow channel for transporting cells post-process, and valves connecting the chambers to the flow channel. He has 1 patent to his name.

Career Highlights

Scott Schmidt is currently associated with Precigen, Inc., where he continues to develop and refine his electroporation technology. His work has the potential to revolutionize how therapeutic agents are delivered, making treatments more effective and accessible.

Collaborations

Scott has collaborated with notable colleagues such as Bryan Butman and Jonathan Carson. Their combined expertise contributes to the innovative environment at Precigen, Inc., fostering advancements in biotechnology.

Conclusion

Scott Schmidt's contributions to electroporation technology exemplify the impact of innovation in biotechnology. His work not only enhances the understanding of cell permeability but also paves the way for future advancements in therapeutic delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…